Healthcare providers across Canada will soon be able to capture adverse events in the Auxita platform through integration with MyMeds&Me’s pharmacovigilance SaaS platform, Reportum.®
This partnership integrates MyMeds&Me’s validated safety data capture solution into Auxita, enabling healthcare providers, patient support programs and pharmaceutical companies to capture and manage data more efficiently.
MyMeds&Me® is a global organization that provides an established end-to-end pharmacovigilance solution to simplify adverse event and product quality data capture. Its drug safety platform, Reportum, is used by pharmaceutical companies around the world to standardize data capture, streamline downstream processes and provide real-time access to complete, relevant safety information.
“Auxita is pleased to expand our service offering to enhance the management of safety data, captured at source from healthcare providers,” says Matt Cahill, CEO of Auxita. “Through our EMR and EHR-integrated platform, we provide an intuitive and standardized digital process to collect data and manage the flow of information throughout the patient journey. This partnership will offer patient support programs real-time access and enhanced visibility to key safety information.”
“Robust pharmacovigilance relies on a comprehensive body of complete, structured, and timely data. Therefore, it is critical that we make safety reporting really easy and intuitive for both physicians and patient support program staff whether in the office or out in the field” says Dr. Andrew Rut, CEO and founder of MyMeds&Me. “Our partnership with Auxita enables efficient capture of standardized information for our clients so they can accelerate safety insights.”
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.